Arcus Biosciences, Inc. (RCUS) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 844M | 1.01B | 857M | 946M | 1.03B | 1.02B | 1.13B | 1.02B | 1.06B | 831M | 881M | 985M |
| Cash & Short-Term Investments | 822M | 981M | 831M | 911M | 997M | 978M | 1.09B | 969M | 995M | 759M | 799M | 930M |
| Cash Only | 201M | 222M | 238M | 248M | 192M | 150M | 201M | 156M | 185M | 127M | 184M | 230M |
| Short-Term Investments | 621M | 759M | 593M | 663M | 805M | 828M | 888M | 813M | 810M | 632M | 615M | 700M |
| Accounts Receivable | 0 | 0 | 14M | 20M | 21M | 25M | 21M | 33M | 40M | 42M | 56M | 37M |
| Days Sales Outstanding | - | - | 60.15 | 11.66 | 73.93 | 81.38 | 51.75 | 85.17 | 25.73 | 145.42 | 133.69 | 114.53 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 22M | 26M | 12M | 15M | 13M | 13M | 17M | 20M | 29M | 30M | 26M | 18M |
| Total Non-Current Assets | 153M | 132M | 117M | 129M | 125M | 134M | 125M | 164M | 229M | 264M | 310M | 235M |
| Property, Plant & Equipment | 38M | 40M | 42M | 44M | 46M | 47M | 48M | 49M | 51M | 51M | 50M | 45M |
| Fixed Asset Turnover | 0.44x | 0.80x | 0.60x | 3.56x | 0.60x | 0.55x | 0.99x | 0.78x | 2.84x | 0.61x | 0.67x | 0.71x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 10M | 16M | 8M | 14M | 2M | 40M | 100M | 107M | 160M | 88M |
| Other Non-Current Assets | 115M | 92M | 65M | 69M | 71M | 73M | 75M | 75M | 78M | 106M | 100M | 102M |
| Total Assets | 997M | 1.14B | 974M | 1.07B | 1.16B | 1.15B | 1.25B | 1.19B | 1.29B | 1.09B | 1.19B | 1.22B |
| Asset Turnover | 0.02x | 0.03x | 0.03x | 0.14x | 0.02x | 0.02x | 0.04x | 0.03x | 0.12x | 0.03x | 0.03x | 0.02x |
| Asset Growth % | -13.75% | -0.96% | -22.2% | -9.36% | -10.6% | 5.02% | 5.12% | -2.79% | 3.11% | -18.59% | -14.55% | -17.39% |
| Total Current Liabilities | 209M | 231M | 235M | 210M | 192M | 226M | 215M | 199M | 204M | 184M | 200M | 180M |
| Accounts Payable | 0 | 0 | 42M | 29M | 22M | 18M | 13M | 15M | 16M | 17M | 17M | 12M |
| Days Payables Outstanding | - | - | 1.63K | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9M | 0 |
| Deferred Revenue (Current) | 34M | 35M | 52M | 71M | 72M | 85M | 105M | 113M | 124M | 91M | 103M | 103M |
| Other Current Liabilities | 175M | 196M | 16M | 16M | 17M | 14M | 86M | 2M | 1M | 39M | 46M | 48M |
| Current Ratio | 4.04x | 4.36x | 3.65x | 4.50x | 5.37x | 4.50x | 5.24x | 5.14x | 5.22x | 4.52x | 4.41x | 5.47x |
| Quick Ratio | 4.04x | 4.36x | 3.65x | 4.50x | 5.37x | 4.50x | 5.24x | 5.14x | 5.22x | 4.52x | 4.41x | 5.47x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 264M | 277M | 303M | 316M | 433M | 439M | 472M | 352M | 382M | 449M | 471M | 474M |
| Long-Term Debt | 100M | 99M | 98M | 97M | 48M | 48M | 47M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 164M | 178M | 152M | 159M | 166M | 157M | 425M | 138M | 140M | 142M | 145M | 144M |
| Total Liabilities | 473M | 508M | 538M | 526M | 625M | 665M | 687M | 551M | 586M | 633M | 671M | 654M |
| Total Debt | 100M | 99M | 111M | 109M | 60M | 60M | 58M | 11M | 11M | 11M | 9M | 0 |
| Net Debt | -101M | -123M | -127M | -139M | -132M | -90M | -143M | -145M | -174M | -116M | -175M | -230M |
| Debt / Equity | 0.19x | 0.16x | 0.25x | 0.20x | 0.11x | 0.12x | 0.10x | 0.02x | 0.02x | 0.02x | 0.02x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -44.67x | -6.00x | -44.00x | 1.00x | -111.00x | -46.00x | -91.00x | - | -3.00x | - | -68.00x | - |
| Total Equity | 524M | 631M | 436M | 549M | 531M | 485M | 565M | 635M | 707M | 462M | 520M | 566M |
| Equity Growth % | -1.32% | 30.1% | -22.83% | -13.54% | -24.89% | 4.98% | 8.65% | 12.19% | 17.83% | -29.68% | -25.58% | -24.27% |
| Book Value per Share | 4.18 | 5.88 | 4.09 | 5.15 | 5.40 | 5.29 | 6.18 | 6.97 | 8.20 | 6.16 | 6.97 | 7.73 |
| Total Shareholders' Equity | 524M | 631M | 436M | 549M | 531M | 485M | 565M | 635M | 707M | 462M | 520M | 566M |
| Common Stock | 2.14B | 2.12B | 1.81B | 1.79B | 1.77B | 1.62B | 1.6B | 1.58B | 1.56B | 1.31B | 1.29B | 1.27B |
| Retained Earnings | -1.61B | -1.49B | -1.38B | -1.24B | -1.24B | -1.13B | -1.04B | -946M | -853M | -849M | -768M | -697M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1M | 0 | 0 | 0 | 0 | 0 | 1M | -1M | -1M | 0 | -3M | -4M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |